Which of the following is an emerging evidence-based intervention for co-occurring mental health in autism?

Question

BlackTom AI · Accepted Answer

Mindfulness-based therapies (for example, adapted Mindfulness-Based Stress Reduction or Mindfulness-Based Cognitive Therapy) have emerged as evidence-based interventions for co-occurring mental health difficulties in autistic people.

1) Relevant knowledge points and concepts
- Co-occurring mental health conditions in autism commonly include anxiety and depression; interventions can be psychological (therapies) or pharmacological.
- “Emerging evidence-based” indicates growing research support but not yet established as first-line across all guidelines.
- Mindfulness therapies target attention, present-moment awareness, and emotional regulation—skills often helpful for anxiety and mood symptoms.

2) Step-by-step reasoning
- Evaluate each option against current evidence:
  a. “Psychotherapy” is a broad label. Some forms (e.g., adapted cognitive behavioral therapy) have solid evidence for anxiety in autism, but the option is nonspecific and not characterized as a single emerging treatment.
  b. “Mindfulness therapy” has multiple recent trials and systematic reviews showing benefits for anxiety, depression, and emotional regulation in autistic adolescents and adults when adapted appropriately—hence described in the literature as an emerging evidence-based approach.
  c. “SSRIs” (selective serotonin reuptake inhibitors) have mixed results in autism: they may help some anxiety/depressive symptoms but evidence is inconsistent and adverse effects can be problematic; they are not broadly categorized as an emerging psychological intervention.
  d. “Melatonin” has good evidence for improving sleep in autistic individuals but addresses sleep problems rather than core co-occurring mood/anxiety disorders.

3) Intermediate considerations
- Mindfulness studies often report reduced anxiety and improved emotional regulation; adaptations (simpler language, sensory considerations) increase feasibility in autism.
- SSRIs and melatonin are pharmacologic and/or symptom-specific; melatonin is for sleep, SSRIs have a less consistent evidence profile for psychiatric comorbidity.

4) Why the correct answer is correct
- Mindfulness therapy fits the phrase “emerging evidence-based intervention” because recent controlled studies and reviews specifically highlight mindfulness-based approaches as promising and increasingly supported for co-occurring mental health issues in autism.

5) Why other options are incorrect (brief)
- a) Too general; not specifically “emerging” as a single labeled intervention.
- c) SSRIs: mixed evidence and concerns about side effects; not the exemplar of “emerging” nonpharmacologic therapy.
- d) Melatonin: evidence supports sleep improvement, not treatment of co-occurring anxiety/depression.

Conclusion: The correct answer is b. Mindfulness therapy. This matches the provided answer.

Which of the following is an emerging evidence-based intervention for co-occurring mental health in autism?单项选择题

类似问题

What are some of the major challenges for developing interventions appropriate for autism? There are multiple correct answers.

Is the following statement true or false? In the products of methylation-hydrolysis, every -OH group corresponds to the position of a glycosidic bond in the starting polysaccharide.

Which of the follwoing structures represents amylopectin?

Which of the following is true about an aldopentose?I. It is a monosaccharide.II. It contains a CHO groupIII. It is a disaccharide.IV. It is an oligosaccharide.

For stock A, we have 𝛽 𝑖 = 0.70. Suppose the expected market risk premium next year is 9% and the risk-free rate is 3%. What is the expected return of this stock based on the CAPM? (Please answer in % and round to 2 decimal places. If the answer is 8.057%, then in the box, write 8.06)

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单